.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
S3V Vascular Technologies recently reached a major milestone in Indian medical innovation. They announced plans to move their indigenous TAVR system India into preclinical evaluation. This phase will validate the safety and design performance of the balloon-expandable device. Consequently, the company hopes for a commercial launch within the next 18 months.
Transcatheter Aortic Valve Replacement (TAVR) offers a minimally invasive alternative for severe aortic stenosis. Traditionally, patients required open-heart surgery for valve issues. However, clinicians can now replace the valve via a catheter. This method significantly reduces recovery time for high-risk or elderly patients. Furthermore, domestic innovation ensures that the technology meets local clinical needs effectively.
Currently, India performs only 4,000 TAVR procedures annually. Nevertheless, the clinical need exceeds 50,000 cases each year. High costs of imported devices create a significant barrier for many patients. Imported systems usually cost between ₹13 lakh and ₹23 lakh. Therefore, S3V aims to democratize care by providing a high-quality, local alternative. This shift could transform cardiac care delivery across the country.
Q1: What is the main benefit of the S3V TAVR system?
A1: It aims to provide a high-quality, affordable local alternative to expensive imported heart valves, increasing accessibility for Indian patients.
Q2: When will the new TAVR system be available?
A2: S3V plans to launch the device commercially within 12 to 18 months, pending successful trials and regulatory approvals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
S3V Vascular Technologies moves its indigenous TAVR system into preclinical trials to lower costs and improve access to cardiac care for Indian patients....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
